5,147 Shares in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Purchased by Sigma Planning Corp

Sigma Planning Corp purchased a new position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 5,147 shares of the company’s stock, valued at approximately $221,000. Sigma Planning Corp owned about 0.11% of SPDR S&P Pharmaceuticals ETF as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Kingsview Wealth Management LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth approximately $11,388,000. BNP Paribas Financial Markets boosted its position in shares of SPDR S&P Pharmaceuticals ETF by 208.6% during the 3rd quarter. BNP Paribas Financial Markets now owns 149,419 shares of the company’s stock worth $6,628,000 after purchasing an additional 101,000 shares during the period. First Citizens Bank & Trust Co. boosted its position in shares of SPDR S&P Pharmaceuticals ETF by 77.2% during the 4th quarter. First Citizens Bank & Trust Co. now owns 127,696 shares of the company’s stock worth $5,490,000 after purchasing an additional 55,643 shares during the period. CX Institutional purchased a new position in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth approximately $438,000. Finally, Stifel Financial Corp purchased a new position in shares of SPDR S&P Pharmaceuticals ETF during the 3rd quarter worth approximately $337,000.

SPDR S&P Pharmaceuticals ETF Stock Performance

NYSEARCA:XPH opened at $44.56 on Friday. The stock has a market capitalization of $162.64 million, a P/E ratio of 15.75 and a beta of 0.73. The company has a 50 day moving average price of $44.22 and a 200 day moving average price of $44.76. SPDR S&P Pharmaceuticals ETF has a fifty-two week low of $38.88 and a fifty-two week high of $48.76.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.